Lu et al31 reported that VEGF blockade with Bev up‐regulates the receptor tyrosine kinase c‐Met activity in GBM cells, resulting in enhanced invasiveness of the cells via activation of the HGF/c‐Met pathway. This evidence concerns the gene NTRK1 and glioblastoma.